Trademark Overview
On Monday, September 30, 2024, a trademark application was filed for RAAVEN with the United States Patent and Trademark Office. The USPTO has given the RAAVEN trademark a serial number of 79409327. The federal status of this trademark filing is NEW APPLICATION - ASSIGNED TO EXAMINER as of Wednesday, March 19, 2025. This trademark is owned by Raaven Therapeutics AB. The RAAVEN trademark is filed in the Computer & Software Services & Scientific Services category with the following description:
Research in the field of gene therapy; biological research, clinical research and medical research; medical research; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; scientific research for medical purposes in the area of cancerous diseases; medical research laboratory services; consultancy relating to research in the field of pharmacogenetics; pharmaceutical research and development; consultancy in the field of pharmaceutical research; platform as a service [PaaS] featuring computer software platforms for use in screening and/or validation within gene therapy research.
